81 related articles for article (PubMed ID: 1089766)
21. Histological grading of gliomas.
Daumas-Duport C
Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):924-31. PubMed ID: 1334739
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapeutic implications of growth fraction and cell cycle time in glioblastomas.
Hoshino T; Wilson CB; Rosenblum ML; Barker M
J Neurosurg; 1975 Aug; 43(2):127-35. PubMed ID: 1185245
[TBL] [Abstract][Full Text] [Related]
23. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
24. Long-term passage results of glioma cells and their cell kinetics.
Matsumura K; Kawamoto K
Hum Cell; 1994 Sep; 7(3):158-66. PubMed ID: 7873500
[TBL] [Abstract][Full Text] [Related]
25. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
26. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
27. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
[TBL] [Abstract][Full Text] [Related]
28. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
29. In situ detection of O6-methylguanine-DNA methyltransferase messenger RNA in paraffin-embedded human astrocytic tumor tissues by nested in situ RT-PCR is useful in predicting chemotherapy-resistance of tumors.
Ohe N; Saio M; Kijima M; Tamakawa N; Suwa T; Kojima Y; Yano H; Kaku Y; Iwama T; Shinoda J; Sakai N; Takami T
Int J Oncol; 2003 Mar; 22(3):543-9. PubMed ID: 12579307
[TBL] [Abstract][Full Text] [Related]
30. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
[TBL] [Abstract][Full Text] [Related]
31. Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.
Schreiber E; Merchant RE; Wiestler OD; Fontana A
Neurosurgery; 1994 Jan; 34(1):129-35. PubMed ID: 8121549
[TBL] [Abstract][Full Text] [Related]
32. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
[TBL] [Abstract][Full Text] [Related]
33. Rapid anaplastic transformation in gliomas of adulthood. "Selection" in neuro-oncogenesis.
Schmitt HP
Pathol Res Pract; 1983 Mar; 176(2-4):313-23. PubMed ID: 6304669
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of tumor cell populations].
Akimov AA; Kozlov AP; Moskalik KG
Vopr Onkol; 1979; 25(8):98-106. PubMed ID: 384668
[No Abstract] [Full Text] [Related]
35. Does dexamethasone inhibit the growth of human gliomas?
Sherbet GV; Lakshmi MS; Haddad SK
J Neurosurg; 1977 Dec; 47(6):864-70. PubMed ID: 925742
[TBL] [Abstract][Full Text] [Related]
36. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
37. Development of anaplastic changes in low-grade astrocytomas of childhood.
Dirks PB; Jay V; Becker LE; Drake JM; Humphreys RP; Hoffman HJ; Rutka JT
Neurosurgery; 1994 Jan; 34(1):68-78. PubMed ID: 8121571
[TBL] [Abstract][Full Text] [Related]
38. Molecular subtypes of glioma identified by genome-wide methylation profiling.
Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
[TBL] [Abstract][Full Text] [Related]
39. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
Schabel FM
Cancer Res; 1969 Dec; 29(12):2384-9. PubMed ID: 5369685
[No Abstract] [Full Text] [Related]
40. Kinetic characteristics of cerebral gliomas.
Hoshino T; Wilson CB
Clin Neurosurg; 1978; 25():326-41. PubMed ID: 213225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]